Li Gang, Director of the Consumption Promotion Department of the Ministry of Commerce (MOC) of China, stated that the ...

Relmada Therapeutics’ attempts to see whether a magic mushroom extract could be used to treat obesity and metabolic diseases ...

Q4 2024 Management View CEO Dan O’Connell highlighted the completion of enrollment for the ALTITUDE AD Phase 2 trial, with 542 participants enrolled in under 10 months. The study focuses on the ...

First-in-human studies anticipated to begin in 2026Engaged a top tier U.S. based contract manufacturer to ensure the highest standards of ...